An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis (Iloprost) in Subjects With Pulmonary Arterial Hypertension.

Trial Profile

An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis (Iloprost) in Subjects With Pulmonary Arterial Hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jan 2013

At a glance

  • Drugs Treprostinil (Primary)
  • Indications Pulmonary hypertension
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 10 Feb 2012 Actual patient number is 73 according to ClinicalTrials.gov.
    • 10 Feb 2012 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top